FDA Updates

FDA, NuCel Labs recalls eye drops and eye/ear wash products

Researchers report a huge drop in preterm birth risk among women taking folic acid one year before conception

Study finds that certain OTC eardrops may cause hearing loss or damage

New branded prescription drugs, new formulations, new indications, generics, OTCs, etc.

OTC allergy drug battle heats up

Women's supplement usage declining

Survey reveals Americans are uneducated about nutrition, multivitamins

Do not use OTC cough and cold products among infants and children under two years of age

Republicans are more likely to used vitamin supplement than Democrats

What OTCs do R.Ph.s recommend for cough & cold season?

Consultant pharmacists applaud CMS' guidelines on nursing home surveyors one year after State Operations Manual guidelines become effective.

Coverage of branded drugs, new indications, new formulations, new dosages, along with OTCs.

Drug Topics conducted an exclusive OTC survey for cough, cold and flu products.

FDA is considering how to deal with the phaseout of chlorofluorocarbons from inhalers, which is only a year away.

SAMHSA: 3.1 million young adults have abused OTC cough medicine in their lifetime.

Drug Topics' poll finds pharmacists against Mevacor going OTC.

FDA issues warning on supplements marketed for ED, sexual enhancement

Legislation introduced to restrict access to DHEA

FDA's final rule mandates warning for nonoxynol 9 OTC contraceptives

CHPA supports FDA's recommendations on phenylephrine

Natural Products Association responds to MLB's Mitchell Report

CHPA responds to NIDA's cough medicine abuse monitoring survey

FDA advisory panel rejects Merck's bid for OTC Mevacor

Drug Topics poll: R.Ph.s favor BTC class of drugs

CRN responds to Informed-Choice report calling for transparency in testing dietary supplements

The FDA has approved Ixabepilone (Ixempra) as a monotherapy and in combination with capecitabine (Xeloda) for patients with metastic or locally advanced breast cancer.

The new products include branded drugs, new formulations, new indications, and new dosing, along with OTCs and home health and beauty items.